In-vitro and In-vivo Toxicology
In vivo toxicology studies are carried out to assess the severity on onset, duration of toxic effects, degree of reversibility and dose dependency. In vitro toxicity testing is a scientific method of analysis for toxic chemical substances on cultured mammalian cell lines or bacterial cell lines. In vitro testing is carried out to identify the chemicals which are potentially hazardous and to confirm the lacking toxic properties at initial stages of development for new possibly useful therapeutic drugs. In vivo toxicological studies are carried out on multiple species such as rodents, guinea pig, rabbits through different routes of exposure such as topical, intravenous, intramuscular etc.
- In-vitro Methods
- In-vivo Methods
- Preclinical Drug Development
- Toxocological Testing
- Predictive Toxicology
Related Conference of In-vitro and In-vivo Toxicology
7th International Conference on Clinical Pharmacology and Toxicology
9th International Conference on Global Toxicology and Risk Assessment
In-vitro and In-vivo Toxicology Conference Speakers
Recommended Sessions
- Applied Pharmacology
- Biochemical and Molecular Toxicology
- Cancer and Chemical Carcinogenesis
- Clinical Pharmacology and Pharmacotherapeutics
- Current Advances in Pharmacology
- Drug Discovery and Toxicity Screening
- Drug Toxicology
- Environmental and Ecotoxicology
- Experimental and Toxicological Pathology
- Food Safety and Toxicology
- Genetic Toxicology
- Human Health and Toxicology
- In-vitro and In-vivo Toxicology
- Industrial and Occupational Toxicology
- Pharmacology
- Product Development Toxicology
- Toxicity Testing Methods
- Toxicologic Risk Assessment
- Toxicology
- Trending Toxicology Concepts
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)

